Ligand-induced down-regulation of the cannabinoid 1 receptor is mediated by the G-protein-coupled receptor-associated sorting protein GASP1

被引:111
作者
Martini, Lene [1 ]
Waldhoer, Maria [1 ]
Pusch, Margareta [1 ]
Kharazia, Viktor [1 ]
Fong, Jamie [1 ]
Lee, Josephine H. [1 ]
Freissmuth, Clarissa [1 ]
Whistler, Jennifer L. [1 ]
机构
[1] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Oakland, CA 94608 USA
关键词
degradation; GPCR; postendocytic sorting; tolerance;
D O I
10.1096/fj.06-7132com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The cannabinoid 1 receptor (CB1R) is one of the most abundant seven transmembrane (7TM) spanning/G-protein-coupled receptors in the central nervous system and plays an important role in pain transmission, feeding, and the rewarding effects of cannabis. Tolerance to cannabinoids has been widely observed after long-term use, with concomitant receptor desensitization and/or down-regulation depending on the brain region studied. Several CB1R agonists promote receptor internalization after activation, but the postendocytic sorting of the receptor has not been studied in detail. Utilizing human embryonic kidney (HEK293) cells stably expressing the CB1R and primary cultured neurons expressing endogenous CB1R, we show that treatment with cannabinoid agonists results in CBIR degradation after endocytosis and that the G-protein-coupled receptor-associated sorting protein GASP1 plays a major role in the postendocytic sorting process. Thus, these results may identify a molecular mechanism underlying tolerance and receptor down-regulation after long-term use of cannabinoids.
引用
收藏
页码:802 / 811
页数:10
相关论文
共 44 条
[1]   In silico patent searching reveals a new cannabinoid receptor [J].
Baker, D ;
Pryce, G ;
Davies, WL ;
Hiley, CR .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (01) :1-4
[2]   Dopamine responsiveness is regulated by targeted sorting of D2 receptors [J].
Bartlett, SE ;
Enquist, J ;
Hopf, FW ;
Lee, JH ;
Gladher, F ;
Kharazia, V ;
Waldhoer, M ;
Mailliard, WS ;
Armstrong, R ;
Bonci, A ;
Whistler, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (32) :11521-11526
[3]   Current evidence supporting a role of cannabinoid CB1 receptor (CB1R) antagonists as potential pharmacotherapies for drug abuse disorders [J].
Beardsley, PM ;
Thomas, BF .
BEHAVIOURAL PHARMACOLOGY, 2005, 16 (5-6) :275-296
[4]   Evidence for a new G protein-coupled cannabinoid receptor in mouse brain [J].
Breivogel, CS ;
Griffin, G ;
Di Marzo, V ;
Martin, BR .
MOLECULAR PHARMACOLOGY, 2001, 60 (01) :155-163
[5]   Chronic Δ9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain [J].
Breivogel, CS ;
Childers, SR ;
Deadwyler, SA ;
Hampson, RE ;
Vogt, LJ ;
Sim-Selley, LJ .
JOURNAL OF NEUROCHEMISTRY, 1999, 73 (06) :2447-2459
[6]   Gender differences in proenkephalin gene expression response to Δ9-tetrahydrocannabinol in the hypothalamus of the rat [J].
Corchero, J ;
Fuentes, JA ;
Manzanares, J .
JOURNAL OF PSYCHOPHARMACOLOGY, 2002, 16 (04) :283-289
[7]  
Coutts AA, 2001, J NEUROSCI, V21, P2425
[8]   Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development [J].
De Vry, J ;
Jentzsch, KR ;
Kuhl, E ;
Eckel, G .
BEHAVIOURAL PHARMACOLOGY, 2004, 15 (01) :1-12
[9]   DOWN-REGULATION OF RAT-BRAIN CANNABINOID BINDING-SITES AFTER CHRONIC DELTA-9-TETRAHYDROCANNABINOL TREATMENT [J].
DEFONSECA, FR ;
GORRITI, MA ;
FERNANDEZRUIZ, JJ ;
PALOMO, T ;
RAMOS, JA .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 47 (01) :33-40
[10]   Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of Δ9-tetrahydrocannabinol-tolerant rats [J].
Di Marzo, V ;
Berrendero, F ;
Bisogno, T ;
González, S ;
Cavaliere, P ;
Romero, J ;
Cebeira, M ;
Ramos, JA ;
Fernández-Ruiz, JJ .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (04) :1627-1635